Links between analysis of surrogate endpoints and endogeneity

Statistics in Medicine

Volumn 29, Issue 28, 2010, Pages 2869-2879

  Ghosh, Debashis ^a   Elliott, Michael R ^b   Taylor, Jeremy M G ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Clinical trial; Counterfactual; Nonlinear response; Prentice criterion; Structural equations model

Indexed keywords

ALGORITHM; ARTICLE; BOOTSTRAPPING; CONCEPTUAL FRAMEWORK; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; COVARIANCE; CRITERION VARIABLE; GLAUCOMA; INSTRUMENT VALIDATION; INTRAOCULAR PRESSURE; LINEAR REGRESSION ANALYSIS; MATHEMATICAL COMPUTING; PROCESS DEVELOPMENT; QUANTITATIVE STUDY; RANDOMIZATION; RISK FACTOR; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STRATIFIED SAMPLE; STRUCTURAL EQUATION MODELING; VALIDATION PROCESS;

ALGORITHMS; BIOLOGICAL MARKERS; BIOSTATISTICS; CAUSALITY; CLINICAL TRIALS AS TOPIC; ENDPOINT DETERMINATION; GLAUCOMA; HUMANS; MODELS, STATISTICAL; NONLINEAR DYNAMICS;

EID: 78649606132     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4027     Document Type: Article

References (31)

1. Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Statistics in Medicine 1989; 8:431-440. DOI: 10.1002/sim.4780080407.
2. Burzykowski T, Molenberghs G, Buyse M. The Evaluation of Surrogate Endpoints. Springer: New York, 2005. DOI: 10.1007/b138566.
3. Daniels MJ, Hughes MD. Meta-analysis for the evaluation of potential surrogate markers. Statistics in Medicine 1997; 16:1965-1982.
4. Gail M, Pfeiffer R, Houwelingen HCV, Carroll RJ. On meta-analytic assessment of surrogate outcomes. Biostatistics 2000; 1:231-246. DOI: 10.1093/biostatistics/1.3.231.
5. Robins JM, Greenland S. Identifiability and exchangeability of direct and indirect effects. International Journal of Epidemiology 1992; 3:143-155. DOI: 10.1097/00001648-199203000-00013.
6. Pearl J. Causality: Models, Reasoning and Inference. Cambridge University Press: Cambridge, 2001.
7. Frangakis CE, Rubin DB. Principal stratification in casual inference. Biometrics 2002; 58:21-29. DOI: 10.1111/j.0006-341X.2002.00021.x.
8. Gilbert PB, Hudgens MG. Evaluating candidate principal surrogate endpoints. Biometrics 2008; 64:1146-1154. DOI: 10.1111/j.1541-0420.2008.01014.x.
9. Li Y, Taylor JMG, Elliott MR. A Bayesian approach to surrogacy assessment using principal stratification in clinical trials. Biometrics 2009; published online August 10. DOI: 10.1111/j.1541-0420.2009.01303.x.
10. Taylor JMG, Wang Y, Thiebaut R. Counterfactual links to the proportion of treatment effect explained by a surrogate marker. Biometrics 2005; 61:1102-1111. DOI: 10.1111/j.1541-0420.2005.00380.x.
11. Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate endpoints for chronic disease. Statistics in Medicine 1992; 11:167-178. DOI: 10.1002/sim.4780110204.
12. Joffe MM, Greene T. Related causal frameworks for surrogate outcomes. Biometrics 2008; 65:530-538. DOI: 10.1111/j.1541-0420.2008.01106.x.
13. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley: New York, 2002.
14. Lancaster T. The Econometric Analysis of Transition Data. Cambridge University Press: Cambridge, 1990.
15. Buyse M, Molenberghs G. Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 1998; 54:1014-1029. DOI: 10.2307/2533853.
16. Pearl J. Causal diagrams for empirical research (with Discussion). Biometrika 1995; 82:669-710. DOI: 10.1093/biomet/82.4.702.
17. Hausman JA. Specification tests in econometrics. Econometrica 1978; 46:1251-1271. DOI: 10.2307/1913827.
18. Wright S. Correlation causation. Journal of Agricultural Research 1921; 20:557-585.
19. Begg CB, Leung DHY. On the use of surrogate endpoints in randomized trials (with Discussion). Journal of the Royal Statistical Society, Series A 2000; 163:15-28.
20. Berger VW. Does the Prentice criterion validate surrogate endpoints? Statistics in Medicine 2004; 23:1571-1578. DOI: 10.1002/sim.1780.
21. Wang Y, Taylor JM. A measure of the proportion of treatment effect explained by a surrogate marker. Biometrics 2002; 58:803-812. DOI: 10.1111/j.0006-341X.2002.00803.x.
22. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. Journal of the American Statistical Association 1996; 91:444-455. DOI: 10.2307/2291629.
23. Angrist JD. Instrumental variables estimation of average treatment effects in econometrics and epidemiology. Working Paper 115, National Bureau of Economics Research. 1991.
24. Bhattacharya J, Goldman D, McCaffrey D. Estimating probit models with self-selected treatments. Statistics in Medicine 2006; 25:389-413. DOI: 10.1002/sim.2226.
25. Buyse M, Molenberghs G, Burzykowski T, Renard D, Geys H. The validation of surrogate endpoints in meta-analyses of randomized experiments. Biostatistics 2000; 1:49-67. DOI: 10.1093/biostatistics/1.1.49.
26. Terza JV, Basu A, Rathouz P. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. Journal of Health Economics 2008; 27:531-543. DOI: 10.1016/j.jhealeco.2007.09.009.
27. Ashley R. Assessing the credibility of instrumental variables inference with imperfect instruments via sensitivity analysis. Journal of Applied Econometrics 2009; 24:325-337. DOI: 10.1002/jae.1044.
28. Musch DC, Lichter PR, Guire KE, Standardi CL. CIGTS investigators. The collaborative initial glaucoma treatment study (CIGTS): Study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 1999; 106:653-662. DOI: 10.1016/S0161-6420(99)90147-1.
29. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. Journal of the American Medical Association 2007; 297:278-285. DOI: 10.1001/jama.297.3.278.
30. Sobel ME. Identification of causal parameters in randomized studies with mediating variables. Journal of Educational and Behavioral Statistics 2008; 33:230-251. DOI: 10.3102/1076998607307239.
31. Joffe M, Small D, Brunelli S, Ten Have T, Feldman H. Extended instrumental variables estimation for overall effects. International Journal of Biostatistics 2008; 4(1). DOI: 10.2202/1557-4679.1082.